Literature DB >> 19539565

Pre-differentiated Th1 and Th17 effector T cells in autoimmune gastritis: Ag-specific regulatory T cells are more potent suppressors than polyclonal regulatory T cells.

Eva N Huter1, Georg H Stummvoll, Richard J DiPaolo, Deborah D Glass, Ethan M Shevach.   

Abstract

Naïve antigen-specific CD4(+) T cells (TxA23) induce autoimmune gastritis when transferred into BALB/c nu/nu mice. Transfer of in vitro pre-differentiated Th1 or Th17 TxA23 effector T cells into BALB/c nu/nu recipients induces distinct histological patterns of disease. We have previously shown that co-transfer of polyclonal naturally occurring Treg (nTreg) suppressed development of Th1-, but not Th17-mediated disease. Therefore, we analysed the suppressive capacity of different types of Treg to suppress Th1- and Th17-mediated autoimmune gastritis. We compared nTreg with polyclonal TGFbeta-induced WT Treg (iTreg) or TGFbeta-induced antigen-specific TxA23 iTreg in co-transfer experiments with Th1 or Th17 TxA23 effector T cells. 6 weeks after transfer in vitro pre-differentiated TxA23 Th1 and Th17 effector cells induced destructive gastritis. Th1-mediated disease was prevented by co-transfer of nTreg and also antigen-specific iTreg, whereas WT iTreg did not show an effect. However, Th17-mediated disease was only suppressed by antigen-specific iTreg. Pre-activation of nTreg in vitro prior to transfer did not increase their suppressive activity in Th17-mediated gastritis. Thus, antigen-specific iTreg are potent suppressors of autoimmune gastritis induced by both, fully differentiated Th1 and Th17 effector cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19539565     DOI: 10.1016/j.intimp.2009.01.022

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  7 in total

1.  Cell-cell interaction with APC, not IL-23, is required for naive CD4 cells to acquire pathogenicity during Th17 lineage commitment.

Authors:  Guangpu Shi; Jenna D Lovaas; Cuiyan Tan; Barbara P Vistica; Eric F Wawrousek; Mehak K Aziz; Rachael C Rigden; Rachel R Caspi; Igal Gery
Journal:  J Immunol       Date:  2012-06-27       Impact factor: 5.422

2.  Smad4 deficiency in T cells leads to the Th17-associated development of premalignant gastroduodenal lesions in mice.

Authors:  Jennifer Nancy Hahn; Vincent George Falck; Frank Robert Jirik
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

Review 3.  Cutting edge issues in autoimmune gastritis.

Authors:  Ban-Hock Toh; James Chan; Tin Kyaw; Frank Alderuccio
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

4.  Multiplexed imaging reveals an IFN-γ-driven inflammatory state in nivolumab-associated gastritis.

Authors:  Selena Ferrian; Candace C Liu; Erin F McCaffrey; Rashmi Kumar; Theodore S Nowicki; David W Dawson; Alex Baranski; John A Glaspy; Antoni Ribas; Sean C Bendall; Michael Angelo
Journal:  Cell Rep Med       Date:  2021-10-19

5.  Disruption of thymic central tolerance by infection with murine roseolovirus induces autoimmune gastritis.

Authors:  Tarin M Bigley; Liping Yang; Liang-I Kang; Jose B Saenz; Francisco Victorino; Wayne M Yokoyama
Journal:  J Exp Med       Date:  2022-02-28       Impact factor: 17.579

6.  Gastric Th17 Cells Specific for H+/K+-ATPase and Serum IL-17 Signature in Gastric Autoimmunity.

Authors:  Chiara Della Bella; Antonio Antico; Maria Piera Panozzo; Nagaja Capitani; Luisa Petrone; Marisa Benagiano; Sofia D'Elios; Clotilde Sparano; Annalisa Azzurri; Sara Pratesi; Fabio Cianchi; Diana Ortiz-Princz; Mathijs Bergman; Nicola Bizzaro; Mario Milco D'Elios
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

Review 7.  Regulation of Gastric Carcinogenesis by Inflammatory Cytokines.

Authors:  Kevin A Bockerstett; Richard J DiPaolo
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-03-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.